Oncoscope is now available on iPad

Request free access to get started

Anna Forsythe at ESMO AI & Digital Oncology 2025

ESMO AI & Digital Oncology Podium Presentation

Last week, Oncoscope-AI Founder & CEO Anna Forsythe gave a podium presentation to a packed room of clinicians, researchers, and industry leaders at ESMO AI & Digital Oncology in Berlin.

The subject? What Oncoscope-AI does best: Living Systematic Review Linked to Guidelines and Regulatory Approvals as a Treatment Decision Support Tool.

Now you can see Anna’s full talk too:

Oncoscope-AI Founder & CEO presents at ESMO AI & Digital Oncology Congress in Berlin, Germany. 12 November 2025.

Oncoscope-AI: Living Systematic Review Linked to Guidelines and Regulatory Approvals as a Treatment Decision Support Tool

Recent posts

As medicine becomes more precise, evidence must become more connected
Oncology Needs Living Evidence, Not More AI Summaries
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical by Anna Forsythe for Forbes
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical

Login

Edge

For physicians seeking patient-level treatment guidance and KOLs shaping the next generation of standards of care.

Enterprise

For pharmaceutical innovators to support strategic decisions and regulatory & reimbursement submissions.